"Expert medical care is right in your neighborhood with the physicians of Atlantic Medical Group. We offer high-quality, compassionate care and are directly connected with renowned specialists and the award-winning hospitals of Atlantic Health System. Schedule an appointment with us today – most major medical insurance plans accepted."

During the past decade, Central New Jersey Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central New Jersey Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Central New Jersey Cardiology" are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Flutter" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Central New Jersey Cardiology" in a lesser frequency.

Most popular intervention types in "Central New Jersey Cardiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Placebo" (1 trials), "apixaban" (1 trials) and "warfarin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central New Jersey Cardiology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Central New Jersey Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central New Jersey Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central New Jersey Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".